Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences has informed the BSE that the trading window for dealing in its securities will remain closed from April 1, 2025, until 48 hours after the announcement of financial results for Q1 FY26 (quarter ended June 30, 2025). This is a routine compliance filing under SEBI's Prohibition of Insider Trading Regulations, 2015, and the company's own insider trading code. The date of the board meeting to consider and approve the Q1 results will be communicated separately. The intimation was signed by Director Dineshkumar Tribhovanbhai Rathod.
This is a standard regulatory disclosure with no direct impact on the stock price. It restricts directors, promoters, and designated employees from trading in the company's shares during the blackout period ahead of the quarterly results, helping prevent insider trading.